Fennec Historical Income Statement
| FENC Stock | USD 6.15 0.01 0.16% |
Historical analysis of Fennec Pharmaceuticals income statement accounts such as Interest Expense of 3.6 M or Selling General Administrative of 21.6 M can show how well Fennec Pharmaceuticals performed in making a profits. Evaluating Fennec Pharmaceuticals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Fennec Pharmaceuticals's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Fennec Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Fennec Pharmaceuticals is a good buy for the upcoming year.
Fennec |
About Fennec Income Statement Analysis
Fennec Pharmaceuticals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Fennec Pharmaceuticals shareholders. The income statement also shows Fennec investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Fennec Pharmaceuticals Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Fennec Pharmaceuticals. It is also known as Fennec Pharmaceuticals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Minority Interest
Minority Interest is the portion of a subsidiary corporation stock that is not owned by the parent corporation. The magnitude of the minority interest in the subsidiary company is generally less than 50% of outstanding shares, otherwise the corporation would generally cease to be a subsidiary of the parent. Minority Interest can also be called non-controlling interest.All shareholders of Fennec Pharmaceuticals whose combined shares represent less than 50% of the total outstanding shares issued by Fennec Pharmaceuticals have a minority interest in Fennec Pharmaceuticals.Most accounts from Fennec Pharmaceuticals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Fennec Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fennec Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.At present, Fennec Pharmaceuticals' Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 22.3 M, whereas Depreciation And Amortization is forecasted to decline to about 272.6 K.
Fennec Pharmaceuticals income statement Correlations
Click cells to compare fundamentals
Fennec Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Fennec Pharmaceuticals income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 64K | 402K | 17.2M | 149K | 287K | 272.7K | |
| Selling General Administrative | 7.4M | 13.0M | 12.2M | 17.7M | 20.6M | 21.6M | |
| Other Operating Expenses | 13.0M | 18.1M | 17.2M | 24.1M | 34.0M | 35.7M | |
| Operating Income | (13.0M) | (17.9M) | (17.2M) | (22.6M) | (12.8M) | (13.4M) | |
| Net Income From Continuing Ops | (12.8M) | (18.1M) | (17.3M) | (23.7M) | (20.2M) | (19.2M) | |
| Ebit | (13.0M) | (18.3M) | (17.3M) | (22.7M) | (12.7M) | (13.3M) | |
| Research Development | 5.6M | 5.1M | 5.0M | 3.5M | 56K | 53.2K | |
| Ebitda | (12.9M) | (17.9M) | (123K) | (22.6M) | (12.4M) | (11.7M) | |
| Total Operating Expenses | 13.0M | 18.1M | 17.2M | 24.0M | 32.8M | 34.4M | |
| Income Before Tax | (12.8M) | (18.1M) | (17.3M) | (23.7M) | (16.0M) | (15.2M) | |
| Total Other Income Expense Net | 234K | (224K) | (123K) | (1.1M) | (3.3M) | (3.1M) | |
| Net Income Applicable To Common Shares | (12.8M) | (18.1M) | (17.3M) | (23.7M) | (21.3M) | (20.3M) | |
| Net Income | (12.5M) | (17.9M) | (17.5M) | (24.8M) | (16.0M) | (15.2M) | |
| Income Tax Expense | (315K) | (187K) | 110K | 1.1M | 1.0 | 0.95 | |
| Non Operating Income Net Other | 521K | 234K | (224K) | (123K) | (110.7K) | (105.2K) | |
| Net Interest Income | 251K | (315K) | (72K) | (932K) | (2.9M) | (2.7M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Fennec Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fennec Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fennec Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fennec Pharmaceuticals Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fennec Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fennec Pharmaceuticals. If investors know Fennec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fennec Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.04) | Revenue Per Share 1.814 | Quarterly Revenue Growth 0.07 | Return On Assets 0.027 | Return On Equity (10.06) |
The market value of Fennec Pharmaceuticals is measured differently than its book value, which is the value of Fennec that is recorded on the company's balance sheet. Investors also form their own opinion of Fennec Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Fennec Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fennec Pharmaceuticals' market value can be influenced by many factors that don't directly affect Fennec Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fennec Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fennec Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fennec Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.